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ABSTRACT 19 
13C-based metabolic flux analysis provides valuable information about bacterial 20 
physiology. Though many biological processes rely on the synergistic functions of 21 
microbial communities, study of individual organisms in a mixed culture using existing 22 
flux analysis methods is difficult. Isotopomer-based flux analysis typically relies on 23 
hydrolyzed amino acids from a homogenous biomass. Thus metabolic flux analysis of a 24 
given organism in a mixed culture requires its separation from the mixed culture. Swift 25 
and efficient cell separation is difficult and a major hurdle for isotopomer-based flux 26 
analysis of mixed cultures. Here we demonstrate the use of a single highly-expressed 27 
protein to analyze the isotopomer distribution of amino acids from one organism. Using 28 
the model organism E.  coli expressing a plasmid-borne, his-tagged Green Fluorescent 29 
Protein (GFP), we show that induction of GFP does not affect E. coli growth kinetics or 30 
the isotopomer distribution in nine key metabolites. Further, the isotopomer labeling 31 
patterns of amino acids derived from purified GFP and total cell protein are 32 
indistinguishable, indicating that amino acids from a purified protein can be used to infer 33 
metabolic fluxes of targeted organisms in a mixed culture. This study provides the 34 
foundation to extend isotopomer-based flux analysis to study metabolism of individual 35 
strains in microbial communities.  36 
 37 
 38 
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INTRODUCTION 42 
Metabolic flux analysis allows insight into a cell’s overall carbon metabolism, 43 
energy production, and the relationship of the genotype to its phenotype1. Development 44 
of typical flux balance models requires assumption of an objective function (often 45 
maximizing the specific growth rate) and a series of physicochemical constraints 46 
(thermodynamic directionality, enzymatic capacity, and reaction stoichiometry)2. For a 47 
complicated metabolic network, there are not always enough constraints to find a unique 48 
solution. Thus, such an approach alone may not accurately describe the reversible 49 
reactions or reactions that may form a futile cycle, especially when the cell’s metabolism 50 
is suboptimal or the annotated pathways are latent under experimental conditions3, 4. For 51 
determination of actual carbon fluxes, 13C based flux analysis is an advanced approach 52 
whereby a 13C-labeled carbon source, such as glucose, is fed to the cells, and the labeling 53 
pattern in resulting metabolites is measured by NMR or GC-MS5-7.  Amino acids arise 54 
from central metabolic pathways and reflect the carbon backbones of their precursors 55 
(Figure 1). The labeling pattern in amino acids provides information about the 13C 56 
distribution in their corresponding precursor metabolites, and thus allows the unique 57 
determination of carbon fluxes in branched pathways or metabolic cycles. In a typical 58 
isotopomer based flux analysis assay, labeled biomass provides the total protein, which is 59 
hydrolyzed to yield the amino acid analyte. Recent advances in isotopomer-based flux 60 
analysis have been applied to numerous microorganisms3, 4, 8-10. Results from such studies 61 
not only quantified fluxes through central metabolic pathways but also provided 62 
experimental evidence for predicted pathways in recently sequenced genomes8, 11, 12. 63 
Since analytes comprise of amino acids derived from total biomass of a culture,  this 64 
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strategy is only applicable to defined monocultures; little is known about the cellular 65 
metabolic network of individual organisms in complicated mixed cultures.  66 
Most naturally-occurring biological processes, ranging from the degradation of 67 
complex organics to elemental cycling, involve the synergistic action of multiple 68 
microorganisms13-21. Understanding how multiple organisms interact and function in a 69 
community is essential to improve their use in bioremediation of contaminated 70 
environments and production of renewable energy22-24. However, it is difficult to monitor 71 
metabolic fluxes of individual organisms in a community because it is not possible to 72 
assign amino acid isotopomer data to the source organism when the sample is derived 73 
from a hydrolysate of the total culture biomass. Traditional separation techniques such as 74 
cell sorting or gradient centrifugation are not efficient for enriching cell types for 75 
isotopomer analysis. Currently, flux analysis for microbial communities is limited to the 76 
study of the entire mixed culture to provide an overall view of the carbon metabolism25. 77 
Here we describe experiments to test the assumption that an enriched pure protein from 78 
an organism can provide the same information as that from total cell protein. While the 79 
origin of an amino acid is ambiguous and cannot be assigned to a sub-population in a 80 
mixed culture, the origins of a protein on the other hand can be fully assigned. As a 81 
result, the use of a single protein for isotopomer-based flux analysis would allow the 82 
study of a microbe in its community.  83 
 84 
 85 
 86 
 87 
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EXPERIMENTAL SECTION 88 
E. coli growth and metabolite assays for isotopomer studies. Difco M9 minimal 89 
salts (5X) were purchased from Becton, Dickinson and Company (Franklin Lakes, NJ). 90 
Unlabeled glucose was obtained from Fisher Scientific (Fair Lawn, NJ) and labeled 91 
glucose (1-13C, 99%) from Cambridge Isotope Laboratories (Andover, MA). Isopropyl β-92 
D-1-thiogalactopyranoside was procured from Sigma-Aldrich (St. Louis, MO). Chelating 93 
sepharose fast flow resin was purchased from GE Healthcare Bio-Sciences (Piscataway, 94 
NJ). 95 
The gene encoding green fluorescence protein (gfp) was cloned in the NcoI and 96 
EcoRI restriction sites in a pET-30 vector (Novagen, Madison, WI) to create the 97 
expression vector pET30-GFP. E. coli DH10B was used for cloning and plasmid 98 
maintenance while E. coli BLR(DE3) was used as the host for protein production. Total 99 
protein and purified GFP in this study were isolated from the wild type (E. coli 100 
BLR(DE3)) or the GFP expression strain (E. coli BLR(DE3) pET30-GFP). All cultures 101 
were grown in M9 minimal medium supplemented with 1% glucose, 0.01 mM FeSO4, 102 
and a trace metal solution26. Shake flasks (250 mL) were used to grow these cultures at 103 
37°C with shaking at 200 rpm. Kanamycin (50 µg/mL) was used for strains containing 104 
pET30-GFP. 105 
To avoid excessive lag time during adaptation to minimal medium, cultures were 106 
subjected to the following procedure. A single colony was used to inoculate 10 mL of 107 
Luria Broth and this culture was grown overnight. An aliquot (500 µL) of this culture 108 
was used to inoculate 20 mL of M9 minimal medium, and this culture was incubated 109 
overnight at 37°C. If the optical density at a wavelength of 600 nm (OD600) of this culture 110 
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was greater than 1.0/mL, the cells were subcultured (2%) into fresh M9 minimal medium 111 
and allowed to grow for 24 hours. This procedure was repeated until the OD600 of 112 
overnight cultures was greater than 3.5/mL for at least two subcultures to adapt cells to 113 
defined medium. One-mL aliquots were stored at -80°C for future use. A thawed aliquot 114 
was used to inoculate overnight cultures in M9 minimal medium, and this culture (0.1%) 115 
was used to inoculate 50 mL of M9 minimal medium for subsequent studies. When the 116 
OD600 of the cultures containing the plasmid reached 0.7/mL, IPTG was added to a final 117 
concentration of 1 mM to induce production of recombinant his-tagged GFP. Cells were 118 
incubated at 37°C for three hours and cell pellets were harvested by centrifugation 119 
(10,000 × g for 20 minutes). Cell growth was monitored by measuring the absorbance at 120 
OD600.  The concentrations of glucose and acetate in the culture medium were measured 121 
using enzyme kits as per the manufacturer’s instructions (r-Biopharm, Darmstadt, 122 
Germany).  123 
 124 
Protein purification. The cell pellets were resuspended in ice-cold, 50 mM 125 
HEPES buffer, pH 8. The cells were lysed by sonication and the total soluble protein was 126 
separated from the insoluble debris by centrifugation (10,000 × g for 30 minutes). The 127 
his-tagged recombinant GFP was purified from the total soluble protein using 128 
immobilized nickel ion affinity chromatography. Briefly, 0.5 mL resin was used in each 129 
case and the resin was prepared according to the manufacturer’s instructions (GE 130 
Healthcare, Piscataway, NJ). Total soluble protein was added to the resin. The resin was 131 
washed with increasing concentrations of imidazole; the protein was eluted with 250 mM 132 
imidazole. Protein samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel 133 
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electrophoresis (SDS-PAGE). To confirm the presence of tagged GFP, a Western blot 134 
was carried out using the S-tag alkaline phosphatase Western blot kit as per the 135 
manufacturer’s instructions (Novagen, Madison, WI). 136 
 137 
Sample preparation for GC-MS. One-mL purified protein (containing about 3 mg 138 
his-tagged GFP) was precipitated using 0.3 mL 60 wt % trichloroacetic acid (TCA). After 139 
adding TCA, samples were incubated at 4°C for 10 min and then centrifuged at 20,000 × 140 
g for 5 min at 4°C. The supernatant was removed, and the protein pellet was washed three 141 
times using 1 mL deionized water followed by three washes with 0.5 mL cold acetone. 142 
These washes minimized carry forward of any residual phosphate salts from the growth 143 
medium and eliminate imidazole and other organic compounds that may interfere with 144 
GC-MS signals. To hydrolyze proteins to amino acids, the protein pellet was dried at 145 
100°C for 2 min, resuspended in 1.5 mL 6 M HCl, and transferred to a clear glass, screw-146 
top GC vial. Vials were capped and incubated at 100°C for 24 hours. After hydrolysis, 147 
the caps were removed and the samples were dried overnight under a stream of air. 148 
GC-MS samples were prepared as previously described8, 11. Briefly, samples were 149 
dissolved in 100 µL tetrahydrofuran (THF) and 100 µL N-(tert-butyldimethylsilyl)-N-150 
methyl-trifluoroacetamide (Sigma-Aldrich, St. Louis, MO). All samples were derivatized 151 
in a water bath at 65-80°C for 1 hour, resulting in tert-butyldimethlysilyl (TBDMS) 152 
derivatives. One µL of the derivatized sample was injected into a gas chromatograph 153 
(Agilent model 6890, Wilmington, DE) equipped with a DB5-MS column (J&W 154 
Scientific, Folsom, CA) and analyzed using a quadrupole mass selective detector (EI) 155 
operated at 70 eV (Agilent 5973, Wilmington, DE). The MS was operated in scan mode 156 
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(started after 4 min, mass range 60-550 a.m.u. at 2.94 s/scan). The sample injection 157 
volume was 1 µL at a carrier gas flow of 2 mL/min helium with a split ratio of 1:20.  The 158 
GC operation conditions were as follows: the GC column was held at 150°C for 2 min, 159 
heated at 3°C per minute to 280°C, heated at 20°C per minute to 300°C, and held for 5 160 
min at that temperature. Two types of positively charged ions were clearly observed by 161 
GC-MS: the derivatized amino acids after the loss of a tert-butyl group [M-57]+, and the 162 
ion after fragmentation at the α-carboxyl group, [M-159]+. The natural abundance of 163 
isotopes was corrected using a published algorithm before using the data for calculating 164 
the label distribution12. 165 
 166 
RESULTS AND DISCUSSION 167 
To test the hypothesis that a pure protein could be used to obtain the isotopomer 168 
data to compute flux for the source organism, two important requirements had to be 169 
fulfilled. First, in using a recombinant protein it was important to assess if production of 170 
GFP affects E. coli central metabolism. Second, it was important to determine if the 171 
isotopomer labeling pattern in amino acids from GFP reflected the labeling pattern in 172 
amino acids from total protein.  173 
The experimental strategy is shown in Figure 2: sample 1 is E. coli BLR(DE3) 174 
cultured with un-labeled glucose; sample 2 is E. coli BLR(DE3) cultured with 99% 1-13C 175 
glucose, samples 3, 4 and 5 are E. coli BLR(DE3) pET30-GFP cultured with 99% 1-13C 176 
glucose and induced for his-tagged GFP production. For isotopomer analysis, amino 177 
acids derived from either hydrolyzed total protein or hydrolyzed purified GFP were used. 178 
Samples 2 and 3 were used for analyzing amino acids from total protein in un-induced 179 
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and induced cultures, respectively. Sample 4 was used for analyzing amino acids from 180 
pure, his-tagged, GFP. Sample 6 was a 1:1 mixture of sample 1 (un-labeled wild-type 181 
biomass) and sample 5 (labeled induced biomass) and represented an artificial mixed 182 
culture from which his-tagged GFP was purified. To prove that protein induction does not 183 
affect central metabolism, the isotopomer data obtained from samples 2 and 3 were 184 
required to be comparable. To establish that a purified protein can be used for an 185 
isotopomer-based flux analysis of the source organism, data from the his-tagged GFP 186 
from sample 6 were required to be equivalent to the data from sample 2.  187 
Under aerobic conditions, all cultures outlined above had a doubling time of ~1 188 
hr. In order to determine the isotopomer patterns in amino acids, samples were taken at 189 
mid-log phase (OD600 ~ 2), which represents a (quasi) steady state that is often used for 190 
flux analysis21. At the time of sampling, glucose consumption and acetate production 191 
were measured (Table 1). No significant difference was observed between the various 192 
cultures, indicating that GFP production did not significantly affect E. coli BLR(DE3) 193 
growth kinetics. Total soluble protein was obtained from the cells as described in the 194 
Materials and Methods section. His-tagged GFP was obtained from total soluble protein 195 
of samples 4 and 6. Total protein was loaded on Ni-charged resin, and bound GFP was 196 
eluted with 250 mM imidazole. All the samples were analyzed by SDS-PAGE. The 197 
elution fractions corresponding to samples 4 and 6 indicated that GFP was more than 198 
99% pure (Figure 3A). A Western blot was carried out to confirm the presence of 199 
recombinant GFP (Figure 3B).  200 
GC-MS analysis is a high-throughput and sensitive (≤ 2% error) method widely 201 
used for 13C isotopomer analysis. Application of GC-MS to resolve derivatized protein 202 
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hydrolysate gave chromatographic peaks corresponding to 16 amino acids (asparagine, 203 
cysteine, glutamine, and tryptophan could not be determined, possibly due to sample 204 
degradation) (Figure 4A). Several amino acid pairs derived from the same precursor, such 205 
as proline and glutamate (from precursor oxoglutarate), threonine and aspartate (from 206 
precursor oxaloacetate), tyrosine and phenylalanine (from precursors 207 
phosphoenolpyruvate and erythrose-4-phosphate), had similar isotopomer distribution 208 
patterns.  Nine key amino acids, representing their precursor’s labeling that are often used 209 
for isotopomer analysis are listed in Table 2, and the remaining amino acids provide 210 
redundant isotopomer information3. Two types of ions were used (Table 2 and Figure 211 
4B): fragment [M-57]+ is the tert-butyldimethylsilyl (TBDMS)-derivatized amino acid 212 
with a loss of the tert-butyl group; fragment [M-159]+ is the TBDMS-derivatized amino 213 
acid with a loss of the COO-TBDMS portion due to a break between the α- and β-carbon 214 
atoms of the amino acid12.   215 
The GC-MS spectra for key amino acids from total protein of wild-type and 216 
induced E. coli, as well as purified GFP (samples 2, 3 and 4) had identical isotopomer 217 
distributions (Table S-1). Isotopomer data of amino acids derived from GFP isolated 218 
from the artificial mixed culture (sample 6) was also equivalent to data from the control 219 
sample (sample 2) (Table 2 and Figure S-1). The difference in isotopomer distribution is 220 
<2%, well within the measurement noise. These results indicate that this method can be 221 
used to investigate the metabolic fluxes in an individual microorganism in a microbial 222 
community using a purified protein. The same strategy may be extrapolated to any 223 
protein that can be isolated in adequate levels and then used to quantify the isotopomer 224 
distribution in the corresponding amino acids.   225 
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While the method outlined in this study is fairly universally applicable and uses 226 
generally accessible reagents and instrumentation, certain precautions were necessary 227 
prior to obtaining accurate spectra for isotopomer analysis. Media used for culturing 228 
bacteria contains phosphate that may remain in the total protein samples. Residual 229 
phosphate can be derivatized and its products interfere with other compounds of interest 230 
during GC-MS separation27. Moreover, reagents such as urea and imidazole that are part 231 
of typical cell lysis and protein purification buffers may also be derivatized by TBDMS 232 
and complicate the GC-MS data acquisition and spectral quality. Examples of urea, 233 
imidazole and phosphate contaminated spectra are provided in Figure S-2. To overcome 234 
this problem, TCA precipitation of proteins followed by extensive washing with water 235 
and acetone proved effective. Another factor to be considered is the quantity of pure 236 
protein required. Despite the sensitivity of GC-MS to detect low sample levels, due to the 237 
multiple clean up steps, efficiency of protein hydrolysis and efficiency of derivatization, 238 
approximately 1 mg of GFP was required to enable detection of all key amino acids 239 
essential for flux analysis. Lower amounts of protein may cause the loss of signal of rarer 240 
amino acids like methionine and histidine. 241 
 242 
CONCLUSIONS 243 
Flux analysis provides key information about cellular metabolism. This 244 
information is central to many studies: physiological characterization of stress responses, 245 
impact of metabolic engineering, to name a few. However, isotopomer-based flux 246 
analysis methods cannot be currently applied to assess the core physiology of an 247 
organism unless it is present in a mono-culture. In order to address this hurdle, we show 248 
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here that the isotopic labeling in key amino acids derived from purified over-expressed 249 
protein in an organism serves as a proxy for total protein of that organism. As it is the 250 
isotopomer data from these key amino acids that are used to determine flux through 251 
central metabolic pathways, the flux distribution information of a target organism in a 252 
mixed culture can be obtained from a single purified protein.  253 
 254 
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FIGURE CAPTIONS 311 
Figure 1. Central metabolic and amino acid biosynthetic pathways.  E4P, erythrose-312 
4-phosphate; F6P, fructose-6-phosphate; G6P, glucose-6-phosphate; PEP, 313 
phosphoenolpyruvate; PGA, 3-phosphoglycerate; C5P, ribose-5-phosphate; T3P, Triose-314 
3-phosphate; and S7P, sedoheptulose 7-phosphate.  315 
 316 
Figure 2. Experimental strategy outlining the various samples used for proof of 317 
concept isotopomer analyses. Samples were numbered as shown. Sample 6 is a mixture 318 
of un-labeled culture (sample 1) and labeled induced culture (sample 5).   319 
 320 
Figure 3. Total protein and pure recombinant GFP used in isotopomer analysis. (A) 321 
Coomassie stained SDS-PAGE analysis of protein samples. Lane 1 contains the ProSieve 322 
color protein marker (Cambrex, Rockland, ME). Lanes 2 and 3 show total soluble 323 
protein, while lanes 4 and 5 show pure, recombinant GFP from samples 4 and 6 324 
respectively. (B) Anti S-tag Western blot to confirm the presence of GFP. Lane 1 325 
contains the ProSieve color protein marker. Lanes 2 and 4 show total soluble protein 326 
while lanes 3 and 5 show pure recombinant GFP obtained from samples 4 and 6, 327 
respectively.  328 
 329 
Figure 4. Gas chromatograph-mass spectrum of amino acids from purified GFP 330 
(sample 6). (A) 16 of the 20 amino acids can be clearly observed in the spectrogram 331 
(glutamine, asparagine, tryptophan, and cysteine were not observed). Standard 332 
abbreviations of amino acids are used to label the corresponding peaks.  (B) Mass 333 
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spectrum of a TBDMS-derivatized amino acid. An amino acid is usually derivatized at 334 
both the carboxylic acid and amino group. The spectrum shown is for glutamic acid, 335 
where ions with m/z = 432 – 437 are the isotopomers of [M-57]+ fragments and the ions 336 
with m/z = 330 – 334 are the isotopomers of [M-159]+ fragments.   337 
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Table 1. Growth kinetics of E. coli after IPTG induction for GFP production. 
 Sample 2 Samples 3, 4 and 5 
Glucose remaining, g/L 7.4 ± 0.3 7.6 ± 0.1 
OD600 ~2 ~2 
Acetate, g/L 0.15 ± 0.02 0.17 ± 0.05 
Doubling time ~1 hr ~1 hr 
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Table 2. Comparison of GC-MS data, total protein and his-tagged GFP.   
Amino acid Precursor/Pathway Iona Total protein from 
BLR(DE3) (sample 2) 
Purified GFP (sample 
6) 
      [-57]a          [-159]     [-57]           [-159]         
M0 0.56±0.01 0.56±0.02 0.55±0.02 0.55±0.01 
M1 0.43±0.02 0.41±0.01 0.44±0.01 0.42±0.02 
Alanine Pyruvate 
M2 0.01±0.0 0.03±0.01 0.01±0.0 0.03±0.01 
M0 0.97±0.03 0.99±0.01 0.99±0.0 1.0±0.0 Glycine Serine 
M1 0.02±0.01 0.01±0.0 0.01±0.0 0.0±0.0 
M0 0.34±0.01 0.33±0.02 0.33±0.01 0.32±0.02 
M1 0.48±0.01 0.47±0.02 0.48±0.01 0.48±0.01 
Valine Pyruvate 
M2 0.17±0.01 0.19±0.01 0.18±0.01 0.19±0.01 
M0 0.20±0.02 0.19±0.02 
M1 0.41±0.02 0.41±0.02 
Leucine Pyruvate & Acetyl-
CoA 
M2 
Peak 
overlap 
0.30±0.01 
Peak 
overlap 
0.31±0.03 
M0 0.23±0.02 0.22±0.01 
M1 0.42±0.02 0.43±0.0 
Isoleucine Pyruvate & 
oxaloacetate 
M2 
Peak 
overlap 
0.27±0.01 
Peak 
overlap 
0.27±0.0 
M0 0.57±0.03 0.61±0.02 0.56±0.02 0.60±0.01 
M1 0.42±0.02 0.38±0.02 0.42±0.01 0.39±0.02 
Serine 3-P-Glycerate 
M2 0.01±0.0 0.01±0.01 0.01±0.0 0.01±0.0 
M0 0.25±0.01 0.24±0.02 0.25±0.02 0.24±0.02 
M1 0.44±0.02 0.45±0.01 0.43±0.02 0.45±0.01 
Phenylalanine P-enolpyruvate 
&Erythrose-4-P 
M2 0.25±0.01 0.23±0.02 0.26±0.01 0.24±0.02 
M0 0.37±0.02 0.43±0.01 0.37±0.01 0.43±0.02 
M1 0.47±0.02 0.44±0.0 0.47±0.02 0.44±0.01 
Aspartic acid Oxaloacetate 
M2 0.10±0.02 0.10±0.01 0.10±0.01 0.10±0.02 
M0 0.26±0.03 0.29±0.02 0.25±0.01 0.29±0.02 
M1 0.42±0.03 0.46±0.02 0.43±0.02 0.45±0.03 
Glutamic acid 2-oxo-glutarate 
M2 0.23±0.01 0.21±0.02 0.23±0.02 0.22±0.01 
M0 0.29±0.03 0.37±0.02 0.28±0.02 0.36±0.02 
M1 0.39±0.02 0.45±0.03 0.39±0.02 0.46±0.02 
Histidine Ribose-5-P 
M2 0.24±0.01 0.15±0.01 0.24±0.01 0.16±0.01 
aM0, M1, M2 represent unlabeled, singly 13C and doubly 13C labeled ions, respectively, of a given fragment. 
Note: the standard error of each measurement was 0~3% (n=2). Ions [-57] of leucine and isoleucine could not be 
resolved because their peaks were overlapped by other peaks, and thus their isotopomer data are not clear. 
